These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18492960)

  • 1. CCB/ACE inhibitor dual therapy for hypertension lowers cardiovascular risk.
    Mitka M
    JAMA; 2008 May; 299(19):2263-4. PubMed ID: 18492960
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Yarows SA
    JAMA; 2003 Apr 23-30; 289(16):2068-9; author reply 2069-70. PubMed ID: 12709458
    [No Abstract]   [Full Text] [Related]  

  • 3. From Tritace to Tri-Plen - the South African journey.
    Cardiovasc J Afr; 2009; 20(1):69-70. PubMed ID: 19287820
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Messerli FH; Weber MA
    JAMA; 2003 Apr 23-30; 289(16):2067-8; author reply 2069-70. PubMed ID: 12709457
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Ong HT
    JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709460
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Chikamori T
    JAMA; 2003 Apr 23-30; 289(16):2066; author reply 2069-70. PubMed ID: 12709456
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Palmer CR; Brown MJ; Mancia G; Ruilope LM;
    JAMA; 2003 Apr 23-30; 289(16):2066-7; author reply 2069-70. PubMed ID: 12709455
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Rifkin W
    JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709459
    [No Abstract]   [Full Text] [Related]  

  • 10. Does it matter how hypertension is controlled?
    Chobanian AV
    N Engl J Med; 2008 Dec; 359(23):2485-8. PubMed ID: 19052130
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular outcomes and antihypertensive drug treatment in older women.
    Bursztyn M
    JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811971
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular outcomes and antihypertensive drug treatment in older women.
    Staessen JA; Thijs L; Wang J; Li Y
    JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811972
    [No Abstract]   [Full Text] [Related]  

  • 13. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Houghton JL
    JAMA; 2003 Apr 23-30; 289(16):2066; author reply 2069-70. PubMed ID: 12709454
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
    Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variability in blood pressure and arterial hypertension].
    Widimský J
    Vnitr Lek; 2011 Mar; 57(3):320-4. PubMed ID: 21495416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 20. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.